Your browser doesn't support javascript.
loading
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections.
Fuentes-Mattei, Enrique; Giza, Dana Elena; Shimizu, Masayoshi; Ivan, Cristina; Manning, John T; Tudor, Stefan; Ciccone, Maria; Kargin, Osman Aykan; Zhang, Xinna; Mur, Pilar; do Amaral, Nayra Soares; Chen, Meng; Tarrand, Jeffrey J; Lupu, Florea; Ferrajoli, Alessandra; Keating, Michael J; Vasilescu, Catalin; Yeung, Sai-Ching Jim; Calin, George A.
Affiliation
  • Fuentes-Mattei E; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Giza DE; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shimizu M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Manning JT; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
  • Tudor S; UMF Carol Davila Bucharest, Romania and Fundeni Hospital, Bucharest, Romania.
  • Ciccone M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Leukemia Department, Santa Anna Hospital, University of Ferrara, Ferrara, Italy.
  • Kargin OA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Zhang X; The RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mur P; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
  • do Amaral NS; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Molecular Morphology Laboratory, AC Camargo Cancer Center, São Paulo 01508-010, Brazil.
  • Chen M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tarrand JJ; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lupu F; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vasilescu C; UMF Carol Davila Bucharest, Romania and Fundeni Hospital, Bucharest, Romania.
  • Yeung SJ; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Calin GA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The RNA Interference and Non-Coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center
EBioMedicine ; 20: 182-192, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28465156
ABSTRACT
Prevalence of Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8) varies greatly in different populations. We hypothesized that the actual prevalence of KSHV/HHV8 infection in humans is underestimated by the currently available serological tests. We analyzed four independent patient cohorts with post-surgical or post-chemotherapy sepsis, chronic lymphocytic leukemia and post-surgical patients with abdominal surgical interventions. Levels of specific KSHV-encoded miRNAs were measured by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and KSHV/HHV-8 IgG were measured by immunoassay. We also measured specific miRNAs from Epstein Barr Virus (EBV), a virus closely related to KSHV/HHV-8, and determined the EBV serological status by ELISA for Epstein-Barr nuclear antigen 1 (EBNA-1) IgG. Finally, we identified the viral miRNAs by in situ hybridization (ISH) in bone marrow cells. In training/validation settings using independent multi-institutional cohorts of 300 plasma samples, we identified in 78.50% of the samples detectable expression of at least one of the three tested KSHV-miRNAs by RT-qPCR, while only 27.57% of samples were found to be seropositive for KSHV/HHV-8 IgG (P<0.001). The prevalence of KSHV infection based on miRNAs qPCR is significantly higher than the prevalence determined by seropositivity, and this is more obvious for immuno-depressed patients. Plasma viral miRNAs quantification proved that EBV infection is ubiquitous. Measurement of viral miRNAs by qPCR has the potential to become the "gold" standard method to detect certain viral infections in clinical practice.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Diseases / RNA, Viral / Viral Load / MicroRNAs Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2017 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Diseases / RNA, Viral / Viral Load / MicroRNAs Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: EBioMedicine Year: 2017 Document type: Article Affiliation country: Estados Unidos